FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077657913> ?p ?o ?g. }

• W2077657913 endingPage "121" @default.
• W2077657913 startingPage "107" @default.
• W2077657913 abstract "The recent clinical and commercial success of anticancer antibodies, such as rituximab (Rituxan) and trastuzumab (Herceptin) has created great interest in antibody-based therapeutics for hematopoietic malignancies and solid tumors. Given the likely lower toxicity for antibodies versus small molecules, the potential increase in efficacy by conjugation to radioisotopes and other cellular toxins and the ability to characterize the target with clinical laboratory diagnostics to improve the drug's clinical performance, it is anticipated that current and future antibody therapeutics will find substantial roles alone and in combination therapy strategies for the treatment of patients with cancer. It is also likely that conjugation strategies will add new radiolabeled and toxin-linked products to the market to complement the recent approvals of ibritumomab tiuxetan (Zevalin) and gemtuzumab ozogamycin (Mylotarg). However, although there are a large number of agents in both early and later stages of clinical development, only a handful will make it through regulatory approval and become successful products. This review considers the structure of anticancer therapeutic antibodies, the techniques used to reduce their antigenicity, factors that influence efficacy and toxicity, conjugation with isotopes and toxins and antibody target validation." @default.
• W2077657913 created "2016-06-24" @default.
• W2077657913 creator A5013721713 @default.
• W2077657913 creator A5034783996 @default.
• W2077657913 creator A5041306207 @default.
• W2077657913 creator A5049185871 @default.
• W2077657913 creator A5059110616 @default.
• W2077657913 creator A5071243384 @default.
• W2077657913 creator A5074059761 @default.
• W2077657913 creator A5081159197 @default.
• W2077657913 creator A5088559019 @default.
• W2077657913 date "2003-02-01" @default.
• W2077657913 modified "2023-09-23" @default.
• W2077657913 title "Antibody-based therapeutics in oncology" @default.
• W2077657913 cites W103585748 @default.
• W2077657913 cites W1497156528 @default.
• W2077657913 cites W1581683172 @default.
• W2077657913 cites W169302176 @default.
• W2077657913 cites W1850867399 @default.
• W2077657913 cites W2030522563 @default.
• W2077657913 cites W2039601524 @default.
• W2077657913 cites W2056483363 @default.
• W2077657913 cites W2057458801 @default.
• W2077657913 cites W2107413762 @default.
• W2077657913 cites W2107466475 @default.
• W2077657913 cites W2119757733 @default.
• W2077657913 cites W2131897751 @default.
• W2077657913 cites W2139210982 @default.
• W2077657913 cites W2167766248 @default.
• W2077657913 cites W2167826135 @default.
• W2077657913 cites W2171213695 @default.
• W2077657913 cites W2185838453 @default.
• W2077657913 cites W2189430385 @default.
• W2077657913 cites W2418073406 @default.
• W2077657913 cites W4246815353 @default.
• W2077657913 doi "https://doi.org/10.1586/14737140.3.1.107" @default.
• W2077657913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12597355" @default.
• W2077657913 hasPublicationYear "2003" @default.
• W2077657913 type Work @default.
• W2077657913 sameAs 2077657913 @default.
• W2077657913 citedByCount "37" @default.
• W2077657913 countsByYear W20776579132013 @default.
• W2077657913 countsByYear W20776579132014 @default.
• W2077657913 countsByYear W20776579132015 @default.
• W2077657913 countsByYear W20776579132018 @default.
• W2077657913 countsByYear W20776579132020 @default.
• W2077657913 countsByYear W20776579132021 @default.
• W2077657913 countsByYear W20776579132023 @default.
• W2077657913 crossrefType "journal-article" @default.
• W2077657913 hasAuthorship W2077657913A5013721713 @default.
• W2077657913 hasAuthorship W2077657913A5034783996 @default.
• W2077657913 hasAuthorship W2077657913A5041306207 @default.
• W2077657913 hasAuthorship W2077657913A5049185871 @default.
• W2077657913 hasAuthorship W2077657913A5059110616 @default.
• W2077657913 hasAuthorship W2077657913A5071243384 @default.
• W2077657913 hasAuthorship W2077657913A5074059761 @default.
• W2077657913 hasAuthorship W2077657913A5081159197 @default.
• W2077657913 hasAuthorship W2077657913A5088559019 @default.
• W2077657913 hasConcept C121608353 @default.
• W2077657913 hasConcept C126322002 @default.
• W2077657913 hasConcept C143998085 @default.
• W2077657913 hasConcept C159654299 @default.
• W2077657913 hasConcept C203014093 @default.
• W2077657913 hasConcept C2776146153 @default.
• W2077657913 hasConcept C2777325958 @default.
• W2077657913 hasConcept C2778245361 @default.
• W2077657913 hasConcept C2778515704 @default.
• W2077657913 hasConcept C2779786085 @default.
• W2077657913 hasConcept C2780653079 @default.
• W2077657913 hasConcept C502942594 @default.
• W2077657913 hasConcept C530470458 @default.
• W2077657913 hasConcept C542903549 @default.
• W2077657913 hasConcept C71924100 @default.
• W2077657913 hasConcept C98274493 @default.
• W2077657913 hasConceptScore W2077657913C121608353 @default.
• W2077657913 hasConceptScore W2077657913C126322002 @default.
• W2077657913 hasConceptScore W2077657913C143998085 @default.
• W2077657913 hasConceptScore W2077657913C159654299 @default.
• W2077657913 hasConceptScore W2077657913C203014093 @default.
• W2077657913 hasConceptScore W2077657913C2776146153 @default.
• W2077657913 hasConceptScore W2077657913C2777325958 @default.
• W2077657913 hasConceptScore W2077657913C2778245361 @default.
• W2077657913 hasConceptScore W2077657913C2778515704 @default.
• W2077657913 hasConceptScore W2077657913C2779786085 @default.
• W2077657913 hasConceptScore W2077657913C2780653079 @default.
• W2077657913 hasConceptScore W2077657913C502942594 @default.
• W2077657913 hasConceptScore W2077657913C530470458 @default.
• W2077657913 hasConceptScore W2077657913C542903549 @default.
• W2077657913 hasConceptScore W2077657913C71924100 @default.
• W2077657913 hasConceptScore W2077657913C98274493 @default.
• W2077657913 hasIssue "1" @default.
• W2077657913 hasLocation W20776579131 @default.
• W2077657913 hasLocation W20776579132 @default.
• W2077657913 hasOpenAccess W2077657913 @default.
• W2077657913 hasPrimaryLocation W20776579131 @default.
• W2077657913 hasRelatedWork W1971030668 @default.
• W2077657913 hasRelatedWork W1973204964 @default.
• W2077657913 hasRelatedWork W2024629263 @default.

• next